Posts by: Carolina Henriques

Carolina Henriques

Carolina holds a BSc in Anthropology and a MSc in Urban Studies., and brings her interdisciplinary skills to her writing on a range of different topics in science, research and advocacy news.

May 15, 2017July 22, 2019

Cigna Extends Insurance Coverage for NeoTract’s UroLift Treatment for Men with BPH

News

Cigna, which provides health insurance to more than 14 million Americans, will extend coverage for the UroLift System, NeoTract’s treatment for benign prostatic hyperplasia (BPH). UroLift is a minimally invasive technology ... Read more

May 10, 2017

Rezūm System Has Treated Over 10,000 BPH Patients in US and Europe, NxThera Announces

News

NxThera has announced that its Rezūm System has been used to safely and effectively treat over 10,000 patients with benign prostate hyperplasia (BPH) by more than 500 physicians in the United ... Read more

May 8, 2017

Rezūm System to Treat BPH Earns 2017 Eureka! Innovation Award

News

NxThera has received a 2017 Eureka! Innovation Award in recognition of the impact its Rezūm system has had on the treatment of benign prostatic hyperplasia (BPH). The award, which honors ... Read more

April 19, 2017April 19, 2017

NeoTract Gets Innovation Award for Implants That Ease Enlarged Prostate Symptoms

News

NeoTract has received a Northern California business development group’s innovation award for creating implants that relieve the symptoms of enlarged prostate without surgery. The #Gamechanger Award was for the UroLift System, which ... Read more

April 5, 2017April 5, 2017

Healthcare Insurers Humana, Aetna to Cover Rezūm System in Treating BPH

News

Humana and Aetna have joined other major insurance companies in covering NxThera’s Rezūm System to treat benign prostatic hyperplasia (BPH), or enlarged prostate. NxThera, a Minnesota-based medical device company, uses radiofrequency thermal technology to ... Read more

March 29, 2017

UroLift System Shows Durable, 5-Year Benefits in BPH Patients in Study, NeoTract Reports

News

NeoTract has released positive, five-year follow-up data from the L.I.F.T. IDE study, evaluating the safety and effectiveness of UroLift system in men with symptomatic benign prostatic hyperplasia (BPH). Five-year results show that ... Read more

March 27, 2017March 27, 2017

UroLift System Featured in BPH/LUTS Training Program for Urology Residents

News

NeoTract’s UroLift system for patients with benign prostate hyperplasia (BPH) was featured in a recent training event of the American Urological Association (AUA) at the AUA headquarters in Linthicum, Maryland. The UroLift ... Read more

March 17, 2017March 18, 2017

Medical Mission to Haiti Successfully Treats BPH Patients With Lumenis Laser Technology

News

Israel’s Lumenis said more than 100 men with benign prostatic hyperplasia (BPH) were treated with the company’s Holmium laser technology during a recent six-day medical mission to Haiti by the nonprofit group GSD Healthcare. The mission, ... Read more

March 1, 2017March 1, 2017

Urologists Meet to Discuss UroLift System as BPH Treatment Option

News

NeoTract recently arranged a meeting with more than 60 urologists across the U.S. to review clinical data and share best practices regarding the use of the UroLift System in caring for people with benign prostate ... Read more

October 17, 2016

Pitt Medical School Awarded $7.7M for New Urology Center to Research BPH, LUTS

News

The National Institutes of Health (NIH) has awarded a $7.7 million grant to the Department of Urology at the University of Pittsburgh School of Medicine to fund the newest O’Brien Urology Cooperative ... Read more